REQUEST FOR ANNUAL FINANCIAL STATEMENTS AND MANAGEMENT’S DISCUSSION AND ANALYSIS (“MD&A”) AND/OR INTERIM FINANCIAL STATEMENTS AND MD&A
To:
CanAlaska Uranium Ltd. (the “Company”)
National Instrument 51-102Continuous Disclosure Obligationsrequires the Company send annually a request form to registered holders and beneficial owners of securities to enable the holders and owners to request a copy of the Company’s annual financial statements and related “MD&A” and/or interim financial statements and related MD&A be mailed to them. These documents may be found on SEDAR atwww.sedar.com or on the Company’s web site atwww.canalaska.com . If you would like to have these documents sent to you, please complete and return this form to:
CANALASKA URANIUM LTD.1020 – 625 Howe Street Vancouver, BC V6C 2T6 Facsimile: 604-688-3217
________ I wish to receive Annual Financial Statements and related MD&A
________ I wish to receive Interim Financial Statements and related MD&A
Name: __________________________ | |
Address: __________________________ | Telephone: _________________________ |
__________________________ | |
__________________________ | Fax number: __________________________ |
Please note:
A request form will be mailed each year. If you wish to receive such materials, a request form must be returned to the Company each year to receive the Annual and/or Interim Financial Statements and related MD&A’s.
If you do not return this request to the Company, you will not be sent the Company’s Annual Financial Statements and related MD&A, or Interim Financial Statements and related MD&A, for the current financial year.
You may also make this request at the Company’s web sitewww.canlaska.com at contact us.
I confirm that I am aregistered / beneficial shareholder of the Company.
SIGNATURE OF SHAREHOLDER:
_________________________
DATE:
_________________________
CUSIP NO: 13708P102
By providing an E-mail address, you will be deemed to be consenting to electronic delivery to you at such E-mail address of the above selected Financial Statements and related MD&A, if delivery by electronic means is allowed by the applicable regulatory rules and policies.
_________________________
E-mail address (optional)